Details of CPPsite entry with Sequence RXRXRXRXRXRXRXRXB |
| Primary information | |
|---|---|
| PEPTIDE SEQUENCE | RXRXRXRXRXRXRXRXB |
| CPPsite ID | 2605, 2606, 2607, |
| PEPTIDE NAME | (RX)8B, (RX)8B, (RX)8B |
| CHIRALITY | Modified, Modified, Modified |
| LINEAR/CYCLIC | Linear, Linear, Linear |
| SOURCE | Synthetic, Synthetic, Synthetic |
| CATEGORY | Cationic, Cationic, Cationic |
| SUB CELLULAR LOCALIZATION | NA, NA, NA |
| N-TERMINAL MODIFICATION | NA, NA, NA |
| C-TERMINAL MODIFICATION | NA, NA, NA |
| CHEMICAL MODIFICATION | X, 6-aminohexanoic acid (Ahx) and B, Beta-Alanine, X, 6-aminohexanoic acid (Ahx) and B, Beta-Alanine, X, 6-aminohexanoic acid (Ahx) and B, Beta-Alanine |
| UPTAKE EFFICIENCY | NA, NA, NA |
| PROPOSED UPTAKE MECHANISM | NA, NA, NA |
| INVITRO/INVIVO | In vitro, In vitro, In vitro |
| CELL LINE | MCF7 cells, MCF7 cells, MCF7 cells |
| In VIVO MODEL | NA, NA, NA |
| CARGO | Nucleic acid [PPMOs targeting translation initiation site of p53 mRNA (M1)], Nucleic acid [PPMOs targeting splice acceptor site of exon 10 (E10SA)], Nucleic acid [PPMOs targeting the coding region within exon 10 |
| PMID | 21765469, 21765469, 21765469 |
| PATENT | Unknown, Unknown, Unknown |
| Tertiary Structure (Technique) | Not Predicted), Not Predicted), Not Predicted), |